Ophthalmic Findings During 10-year Enzyme Substitution of Danish Fabry Patients.
NCT01997489
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
39
Enrollment
OTHER
Sponsor class
Conditions
Fabry Disease
Interventions
DRUG:
Enzyme replacement
Sponsor
Rigshospitalet, Denmark